Picture of Stratec SE logo

SBS Stratec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Brief: STRATEC SE Q3 Adjusted EBIT Margin Of 14.8%

Oct 27 (Reuters) - STRATEC SE  SBSG.DE :
    * STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
    * SIGNIFICANT INTRA-YEAR IMPROVEMENT IN PROFITABILITY IN Q3
OF
2023
    * ADJUSTED EBIT MARGIN OF 14.8% IN Q3/2023
    * SALES PERFORMANCE STILL ADVERSELY AFFECTED BY EXCESS
MOLECULAR
DIAGNOSTICS CAPACITIES BUILT UP DURING PANDEMIC;
CONSTANT-CURRENCY SALES -9,1% IN 9M/2023
    * FINANCIAL GUIDANCE FOR 2023: SALES GUIDANCE SLIGHTLY
ADJUSTED
AND MARGIN TARGET CONFIRMED

Source text for Eikon:  ID:nEQ3kRXkWa 
Further company coverage:  SBSG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))

Recent news on Stratec SE

See all news